About Us / Blogs

Gene Editing Services

Ubigene has modified over 5000 genes from more than 100 cell lines with our exclusive innovation CRISPR-U™ technology. At the same time, we already provide customers with high quality gene-editing tools for cell or animal research worldwide.

Stable Cell Lines

Knockout Cell Lines

Knockdown Cell Lines

Overexpression Cell Lines

Knockin Cell Lines

Cloning Services

Knockout Plasmid

Point Mutation Plasmid

Knockin Plasmid

Overexpression Plasmid

Knockdown Plasmid

Virus Packaging

Lentivirus Packaging

Adenovirus Packaging

Adeno-associated Virus Packaging

CRISPR Library

Customized CRISPR Library

CRISPR Library In-stock

Microbe

Knockout E.coli

Knockout Salmonella

Cell Assay

Cell Proliferation

Cell Migration and Invasion

Cell Cycle

Cell Apoptosis

Detection of Marker Protein Expression

Cytokine Secretion and Enzyme Activity Test

Cytotoxicity Test

EZ-editor™
Gene-editing Series Products

With 12 years of experience, Ubigene has exclusively innovated and developed 6 product lines, fullfilling all kinds of needs from researchers. Experiment process simplified, efficiency improved, achieving our aim of 'Make genome editing easier'!

Red Cotton™ gRNA Plasmid Bank

Regular Plasmid

Lentiviral Plasmid

EZ-editor™ Culture Medium

Transfection Culture Medium

Cell Monoclonal Culture Medium

Knockout-cell-lysate

KO cell lysates (clone)

KO cell lysates (pool)

EZ-editor™ Cell Line

KO Cell Lines

Wild-type Cell Lines

Cas9 Stable Cell Lines

Luciferase Stable Cell Lines

EGFP Stable Cell Lines

EZ-editor™ Kits

Monoclone Validation Kit (extraction free)

EZ-editor™ Gene Knockout kit

Lentiviral Packaging Kit

Mycoplasma Treatment kit

Lentivirus

Red Cotton Gene knockout Project

Ubigene exclusive KO Cell Line Bank, over 5000 KO cell lines, covering thousands of genes from 8 popular signaling pathways and nearly 100 diseases.

Red Cotton CRISPR Gene Editing Designer

Gene Editing Cell Designer

Gene Editing Microbe Designer

Gene Editing Tool Kit

Red Cotton Gene knockout Project

Location：Home > About Us > Blogs >

Contact us✖

* Name：

Institution：

* Project Description：

* How would you like us to contact you?

* E-mail：

Phone：

WhatsAPP：

FaceBook Messenger：

Our Solution Specialists will contact you within 2 business days. Of course, you can also tell us when you would like to be contacted:

Select：

Source：

Other

Recommendations from others

CRISPR-Nanopore Sequencing Combo Could Revolutionize Cancer Gene Identification

The speed and accuracy w ith which current sequencing platforms can produce results are quite staggering compared to methodologies that were being utilized less than ten years ago. Yet, when it comes to making clinical decisions with respect to cancerous tumors, sequencing assays …
2020-02-26
The first CRISPR gene therapy is safe

In November, researchers announced the results of the first US CRISPR gene therapy. Now the data are out in a peer-reviewed paper, and here are comments on the results from leading researcher Carl June and experts in the field.
2020-02-25
Preliminary Results Point to Success of In Vivo Gene Editing

Two studies show signs that the introduced DNA is functioning, but it’s too early to know if patients actually benefit.
2020-02-25
Reproductive genome from the laboratory

Synthetic biology researchers have developed a genome the size of a minimal cell that can copy itself.
2020-02-21
Genome stability: Intricate process of DNA repair discovered

An elaborate system of filaments, liquid droplet dynamics and protein connectors enables the repair of some damaged DNA in the nuclei of cells, researchers have found. The findings further challenge the belief that broken DNA floats aimlessly -- and highlight the value of cross-di…
2020-02-19
Molecular 'switch' reverses chronic inflammation and aging

Scientists have identified a molecular 'switch' that controls the immune machinery responsible for chronic inflammation in the body. The finding could lead to new ways to halt or even reverse many age-related conditions, from from Alzheimer's and Parkinson's to diabetes and cancer…
2020-02-18
Base Editing Promise in Treating a Mouse Model of Progeria

David Liu, PhD, presents in vivo results showing proof-of-principle of base editing in correcting the gene defect responsible for a premature aging genetic disorder in mice.
2020-02-17
CRISPR-Edited Cells for Cancer Therapy Safe in Humans: Trial

In the first clinical study of its kind in the US, researchers used CRISPR to modify CAR T cells to make them more potent against cancer, but the clinical benefits are unknown.
2020-02-14
Successful T cell engineering with gene scissors

The idea of genetically modifying a patient's own immune cells and deploying them against infections and tumors has been around since the 1980s. But to this day modified T cells are still not as effective as natural T cells and have been only been of limited clinical value. Using …
2020-02-14